Visual mismatch negativity: a predictive coding view G Stefanics, J Kremláček, I Czigler Frontiers in human neuroscience 8, 666, 2014 | 341 | 2014 |
Motion-onset VEPs: characteristics, methods, and diagnostic use M Kuba, Z Kubová, J Kremláček, J Langrová Vision research 47 (2), 189-202, 2007 | 196 | 2007 |
Visual mismatch negativity (vMMN): A review and meta-analysis of studies in psychiatric and neurological disorders J Kremláček, K Kreegipuu, A Tales, P Astikainen, N Poldver, R Näätänen, ... Cortex 80, 76-112, 2016 | 139 | 2016 |
Behavioral effects of antiepileptic drugs in rats: Are the effects on mood and behavior detectable in open-field test? E Zimcikova, J Simko, I Karesova, J Kremlacek, J Malakova Seizure 52, 35-40, 2017 | 125 | 2017 |
Visual mismatch negativity among patients with schizophrenia A Urban, J Kremláček, J Masopust, J Libiger Schizophrenia research 102 (1-3), 320-328, 2008 | 84 | 2008 |
Motion-onset VEPs reflect long maturation and early aging of visual motion-processing system J Langrová, M Kuba, J Kremláček, Z Kubová, F Vit Vision Research 46 (4), 536-544, 2006 | 81 | 2006 |
Aging effect in pattern, motion and cognitive visual evoked potentials M Kuba, J Kremláček, J Langrová, Z Kubová, J Szanyi, F Vít Vision research 62, 9-16, 2012 | 72 | 2012 |
Visual mismatch negativity elicited by magnocellular system activation J Kremláček, M Kuba, Z Kubová, J Langrová Vision Research 46 (4), 485-490, 2006 | 64 | 2006 |
Motion-onset VEPs to translating, radial, rotating and spiral stimuli J Kremláček, M Kuba, Z Kubova, J Chlubnova Documenta Ophthalmologica 109, 169-175, 2004 | 61 | 2004 |
Systemic inflammation, oxidative damage to nucleic acids, and metabolic syndrome in the pathogenesis of psoriasis L Borska, J Kremlacek, C Andrys, J Krejsek, K Hamakova, P Borsky, ... International journal of molecular sciences 18 (11), 2238, 2017 | 53 | 2017 |
Effect of stimulus localisation on motion-onset VEP J Kremláček, M Kuba, J Chlubnová, Z Kubová Vision Research 44 (26), 2989-3000, 2004 | 53 | 2004 |
Gender impact on electrophysiological activity of the brain. J Langrova, J Kremláček, M Kuba, Z Kubova, J Szanyi Physiological research 61, 2012 | 48 | 2012 |
Serum levels of the pro‐inflammatory cytokine interleukin‐12 and the anti‐inflammatory cytokine interleukin‐10 in patients with psoriasis treated by the Goeckerman regimen L Borska, C Andrys, J Krejsek, K Hamakova, J Kremlacek, K Ettler, Z Fiala International journal of dermatology 47 (8), 800-805, 2008 | 48 | 2008 |
Lack of visual evoked potentials amplitude decrement during prolonged reversal and motion stimulation in migraineurs M Bednář, Z Kubová, J Kremláček Clinical Neurophysiology 125 (6), 1223-1230, 2014 | 43 | 2014 |
Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8. L Borská, Z Fiala, J Krejsek, C Andrýs, D Vokurková, K Hamáková, ... Physiological research 55 (6), 2006 | 39 | 2006 |
Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis M Beranek, Z Fiala, J Kremlacek, C Andrys, J Krejsek, K Hamakova, ... Archives of Dermatological Research 309, 815-821, 2017 | 36 | 2017 |
Electrophysiological testing of dyslexia M Kuba, J Szanyi, D Gayer, J Kremlácek, Z Kubová ACTA MEDICA-HRADEC KRALOVE- 44 (4), 131-134, 2001 | 36 | 2001 |
Genotoxic effect of Goeckerman regimen of psoriasis Z Fiala, L Borska, A Pastorkova, J Kremlacek, M Cerna, J Smejkalova, ... Archives of dermatological research 298, 243-251, 2006 | 35 | 2006 |
Oxidative Damage to Nucleic Acids and Benzo (a) pyrene‐7, 8‐diol‐9, 10‐epoxide‐DNA Adducts and Chromosomal Aberration in Children with Psoriasis Repeatedly Exposed to Crude … L Borska, C Andrys, J Krejsek, V Palicka, M Chmelarova, K Hamakova, ... Oxidative Medicine and Cellular Longevity 2014 (1), 302528, 2014 | 31 | 2014 |
Visual evoked potentials to pattern, motion and cognitive stimuli in Alzheimer’s disease Z Kubová, J Kremláček, M Vališ, J Langrová, J Szanyi, F Vít, M Kuba Documenta ophthalmologica 121, 37-49, 2010 | 30 | 2010 |